New pill aims to tame dangerous lupus kidney damage
NCT ID NCT07363460
Summary
This study is testing whether a new daily pill called HSK39297 can help control lupus nephritis, a serious kidney disease caused by lupus. About 105 adults with active kidney inflammation will take either the real pill or a placebo, along with standard care, to see if it reduces kidney damage and protein in the urine. The main goal is to see if the treatment is safe and more effective than a placebo at improving kidney health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS (LN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
RECRUITINGNanjing, Jiangsu, 210000, China
Conditions
Explore the condition pages connected to this study.